Health care startups that raised Series C in Jiangsu, China
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Kossel Medical | Suzhou | Series C | $59.5M | 2026-09-01 |
| Weikaier Pharmaceutical Technology | Nanjing | Series C | $29.6M | 2026-06-02 |
| SmartNuclide | Suzhou | Series C | $13.8M | 2024-04-09 |
| Zenshine Pharma | Nanjing | Series C | $13.7M | 2023-10-13 |
| Care Medical | Suzhou | Series C | $13.6M | 2023-09-08 |
| Fucunbao | Jiangyin | Series C | $11.4M | 2021-03-15 |
| Miao | Suzhou | Series C | $74.4M | 2019-04-02 |
7 rows of the CSV in 5 of its 18 columns.
- The 52 health care startups in Jiangsu, China whose last round is Series C have raised $1.9B in total.
- 8 of them closed their most recent round in the last 12 months, $268.7M combined.
- The largest of those rounds is Kossel Medical's $59.5M Series C, dated September 2026.
- China Life Private Equity Investment is an investor in 2 of them, more than any other fund.
- Biotech is the most common other sector, with 24 companies (46%).
- 4% were founded in 2020 or later; the median founding year is 2015.
- The most common team size is 101 to 250 employees (24% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
3 of 52| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Kossel Medical | Kossel Medical develops and manufactures vascular interventional devices and clinical system solutions. | Health care | Suzhou | Series C | $59.5M | 2026-09-01 | $103.0M | Fortune Venture Capital, Suzhou International Development Venture Capital, Ming Bioventures +1 | 501 to 1,000 | 2013 |
| Weikaier Pharmaceutical Technology | Weikaier Pharmaceutical Technology conducts drug research, transfers generic drug technology, and produces and sells pharmaceuticals. | Biotech | Nanjing | Series C | $29.6M | 2026-06-02 | $120.4M | SDIC Venture Capital, Dyee Capital, Nanjing Innovation Capital Group +1 | 501 to 1,000 | 2010 |
| Zenshine Pharma | Zenshine Pharma develops small molecule drugs for cancer and autoimmune diseases. | Biotech | Nanjing | Series C | $13.7M | 2023-10-13 | $28.7M | Matrix Partners China, Cybernaut Venture Capital, Kunlun Capital +2 | 11 to 50 | 2018 |
Table 1. Health care startups that raised Series C in Jiangsu, China: the 3 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 52.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Kossel Medical | Kossel Medical develops and manufactures vascular interventional devices and clinical system solutions. | Health care | Suzhou | Series C | $59.5M | 2026-09-01 | $103.0M | Fortune Venture Capital, Suzhou International Development Venture Capital, Ming Bioventures +1 | 501 to 1,000 | 2013 |
| 2 | Weikaier Pharmaceutical Technology | Weikaier Pharmaceutical Technology conducts drug research, transfers generic drug technology, and produces and sells pharmaceuticals. | Biotech | Nanjing | Series C | $29.6M | 2026-06-02 | $120.4M | SDIC Venture Capital, Dyee Capital, Nanjing Innovation Capital Group +1 | 501 to 1,000 | 2010 |
Table 2. Health care startups that raised Series C in Jiangsu, China: the 2 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | China Life Private Equity Investment | Private equity firm | Beijing, China | 2 | 4% | 1 | Weikaier Pharmaceutical Technology |
| 2 | Ming Bioventures | Venture capital firm | Suzhou, China | 1 | 2% | 1 | Kossel Medical |
| 3 | Suzhou International Development Venture Capital | Venture capital firm | Suzhou, China | 1 | 2% | 1 | Kossel Medical |
| 4 | Fortune Venture Capital | Venture capital firm | Shenzhen, China | 1 | 2% | 1 | Kossel Medical |
| 5 | Yueyin Venture Capital | Venture capital firm | Beijing, China | 1 | 2% | 1 | Kossel Medical |
| 6 | SDIC Venture Capital | Venture capital firm | Xicheng, China | 1 | 2% | 1 | Weikaier Pharmaceutical Technology |
| 7 | Nanjing Innovation Capital Group | Venture capital firm | Nanjing, China | 1 | 2% | 1 | Weikaier Pharmaceutical Technology |
| 8 | Dyee Capital | Private equity firm | Xiamen, China | 1 | 2% | 1 | Weikaier Pharmaceutical Technology |
| 9 | Dynamic Balance Capital | Venture capital firm | Nanjing, China | 1 | 2% | ||
| 10 | Kington Capital | Venture capital firm | Suzhou, China | 1 | 2% | ||
| 11 | Longmen Capital | Venture capital firm | Shenzhen, China | 1 | 2% | ||
| 12 | Jiuyou Capital | Private equity firm | Guangdong, China | 1 | 2% | ||
| 13 | Oriza Holdings | Venture capital firm | Suzhou, China | 1 | 2% | ||
| 14 | Chuanggu Capital | Venture capital firm | Hefei, China | 1 | 2% | ||
| 15 | Huaying | Venture capital firm | Shenzhen, China | 1 | 2% |
Table 3. Health care startups that raised Series C in Jiangsu, China: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
Table 4. Health care startups that raised Series C in Jiangsu, China by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Series C | 52 | 100% | $26.1M |
Table 5. Health care startups that raised Series C in Jiangsu, China by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Suzhou | 23 | 44% |
| Nanjing | 18 | 35% |
| Taizhou | 4 | 8% |
| Nantong | 1 | 2% |
| Jiangning | 1 | 2% |
| Qidong | 1 | 2% |
| Huaiyin | 1 | 2% |
| Changsha | 1 | 2% |
| Jiangyin | 1 | 2% |
| Wuxi Shi | 1 | 2% |
Table 6. Health care startups that raised Series C in Jiangsu, China by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| September 2026 | 1 | 12% | $59.5M |
| July 2026 | 1 | 12% | $29.5M |
| June 2026 | 1 | 12% | $29.6M |
| May 2026 | 1 | 12% | $50.0M |
| March 2026 | 2 | 25% | $35.3M |
| February 2026 | 1 | 12% | $50.6M |
| December 2025 | 1 | 12% | $14.2M |
Table 7. Health care startups that raised Series C in Jiangsu, China: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 7 | 13% | $254.5M |
| 2025 | 7 | 13% | $125.5M |
| 2024 | 7 | 13% | $57.9M |
| 2023 | 5 | 10% | $32.8M |
| 2022 | 6 | 12% | $134.3M |
| 2021 | 8 | 15% | $831.1M |
Table 8. Health care startups that raised Series C in Jiangsu, China by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2020 to 2022 | 2 | 4% |
| 2015 to 2019 | 26 | 50% |
| 2010 to 2014 | 20 | 38% |
| Before 2010 | 4 | 8% |
Table 9. Health care startups that raised Series C in Jiangsu, China by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 3 | 6% |
| 11 to 50 | 10 | 20% |
| 51 to 100 | 8 | 16% |
| 101 to 250 | 12 | 24% |
| 251 to 500 | 5 | 10% |
| 501 to 1,000 | 7 | 14% |
| 1,001 to 5,000 | 4 | 8% |
Table 10. Health care startups that raised Series C in Jiangsu, China by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Health care is one of its sectors and its most recent funding round is Series C and its headquarters is in Jiangsu, China. On 16 November 2026 that is 52 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 3 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 52 rows: 13 have no round amount, 0 no city and 8 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many health care startups in Jiangsu, China whose last round is Series C are on the list?
- 52, in the file dated 16 November 2026. 8 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 52 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.